| All (67=100%) | ELN−(42=63%) | ELN+ (25=37%) | P value | |
|---|---|---|---|---|
| Female, % | 48 (71%) | 29 (69%) | 19 (76%) | 0.54 |
| Age, mean ± SD | 51±17 | 50±17 | 52±17 | 0.72 |
| Dis dur (mo), mean ± SD | 5±3 | 5±2 | 5±3 | 0.72 |
| ESR, mean ± SD | 39±27 | 33±26 | 48±26 | 0.01 |
| CRP, mean ± SD | 19±32 | 20±38 | 19±19 | 0.07 |
| IgM RF, % | 43 (65%) | 22 (53%) | 21 (84%) | 0.01 |
| CCP, % | 46 (68%) | 25 (59%) | 21 (84%) | 0.03 |
| DAS28, mean ± SD | 5.8±1.3 | 5.6±1.4 | 6.2±0.8 | 0.05 |
| HAQ, mean ± SD | 1.60±0.69 | 1.65±0.68 | 1.53±0.73 | 0.15 |
| Use of oral steroid, % | 43 (64%) | 24 (57%) | 19 (76%) | 0.11 |